Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal
In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year
Bosnian Research Trying To Leave, Asks For More Calls
ACS Urges Practice Of Insurance Exclusion End Under Reform
Epstein Petition Seeks Broder’s Removal As NCI Director
NIH Should Review CRADA Pricing, Wyden Write to Shalala
IOM Selects Advisors To Defense Department
“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy
FDA Policy On Support Of Medical Education Near Final Form
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
